Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Revenue

Sunmax Biotechnology had revenue of 564.82M TWD in the quarter ending March 31, 2026, with 1.92% growth. This brings the company's revenue in the last twelve months to 2.04B, up 4.74% year-over-year. In the year 2025, Sunmax Biotechnology had annual revenue of 2.03B with 11.45% growth.

• Revenue (ttm): 2.04B
• Revenue Growth: +4.74%
• P/S Ratio: 10.16
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 20.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.03B	208.15M	11.45%
Dec 31, 2024	1.82B	129.03M	7.64%
Dec 31, 2023	1.69B	288.91M	20.64%
Dec 31, 2022	1.40B	364.42M	35.19%
Dec 31, 2021	1.04B	179.81M	21.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error